Перегляд вихідного коду сторінки What You Have To Understand About MMP23B And Why

2% crystal violet, and counted in high powered fields (100 ��) with light microscope. Statistical analysis Statistical analysis was performed using SPSS 17.0 software (SPSS Inc., Chicago, USA). Chi-square or Fischer��s exact tests were used for evaluating the relationship between methylation status [http://www.selleckchem.com/products/abt-199.html Venetoclax in vivo] and clinic-pathological characteristics. All experiment data are presented as means �� standard deviation (SD) of at least three independent experiments. Two-sided tests were used to determine significance, and p [http://en.wikipedia.org/wiki/MMP23B MMP23B] increased expression was obtained in HCT116 cell line (Figure 1D). These results demonstrate that BCL6B expression was regulated by promoter region methylation in colorectal cancer. To further validate the efficiency of MSP primers and the density of methylation in BCL6B promoter region, bisulfite sequencing was performed. MSP results were matched with bisulfite sequencing very well (Figure 1E). Figure 1 Representative results of BCL6B expression and methylation [http://www.selleckchem.com/products/pci-32765.html Ibrutinib cost] in Colorectal cancer cells. A. BCL6B expression was detected by semi-quantitative RT-PCR in 7 colorectal cancer cell lines (RKO, HT-29, DLD1, LOVO, HCT116, SW480, SW620) and 4 cases of normal ... BCL6B was frequently methylated and the expression was reduced in human primary CRC To analyze the methylation status of BCL6B in human primary CRC, 102 cases of primary CRC were detected by MSP. As shown in Figure 2A, 79.4% (81/102) of CRC was methylated. BCL6B expression was evaluated by Immunohistochemistry in 32 cases of available matched CRC and adjacent tissue samples. The expression is mainly in cytoplasm. The expression was reduced significantly in primary cancer compared with adjacent tissue samples (p